Aprepitant-associated ifosfamide neurotoxicity.
Hansen Ho
Yuen
Courtney
C
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects; D000077608:Aprepitant; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects*; D020258:Neurotoxicity Syndromes / Q000453:epidemiology* / Q000209:etiology; D012189:Retrospective Studies; D012509:Sarcoma / Q000188:drug therapy / Q000453:epidemiology
D000928:Antidepressive Agents; D018906:Antineoplastic Agents, Alkylating; D009025:Morpholines; D000077608:Aprepitant; D007069:Ifosfamide